| Univariate | Multiple |
---|---|---|
Age (y) | 0.98 (0.95-1.02) | 1.00 (0.97-1.04) |
Lymph node ratio†| 1.06 (1.02-1.11)* | - |
Gender | Â | Â |
 Female | Reference | Reference |
 Male | 1.75 (0.55-5.58) | 2.19 (0.59-8.20) |
Location of tumor | Â | Â |
 Colon | Reference | - |
 Rectum | 1.16 (0.40-3.30) | - |
Depth of invasion | Â | Â |
 T1 or T2 | Reference | - |
 T3 | 2.23 (0.47-10.51) | - |
 T4 | 1.03 (0.19-5.63) | - |
Stage | Â | Â |
 I | Reference | - |
 II | 0.83 (0.09-8.02) | - |
 III | 4.60 (0.59-36.07) | - |
Tumor grade | Â | Â |
 I | Reference | - |
 II | 0.95 (0.12-7.41) | - |
 III | 0.69 (0.06-7.67) | - |
Upstage | Â | Â |
 N0(i+) | 9.97 (1.40-71.07)* | 8.07 (1.09-59.50)* |
 N0 | Reference | Reference |
 N+ | 9.67 (2.10-44.47)* | 7.87 (1.68-36.79)* |
HE examination | Â | Â |
 Negative | Reference | - |
 Positive | 5.93 (1.84-19.12)* | - |
SLN examination | Â | Â |
 Negative | Reference | - |
 Positive | 1.11 (0.25-4.96) | - |